AEs	Adverse Events
BRAFi	BRAF inhibitor
BRAFmut	BRAF mutated
CR	Complete Response
DTIC	Dacarbazine
EGFR	Epidermal Growth Factor Receptor
EMA	European Medicine Agency
ERK	Extracellular Signal-Regulated Kinase
FDA	Food and Drug Administration
HDAC	Hystone Deacetylase
HGF	Hepatocyte Growth Factor
IFN	Interferon
MHC	Major Histocompatibility Complex
MAPK	Mitogen-Activated Protein Kinase
MEKi	MEK inhibitor
NRASmut	NRAS mutated
ORR	Overall Response Rate
OS	Overall Survival
PFS	Progression-free Survival
RR	Response Rate
UPAR	Urokinase Plasminogen Activator Receptor